About the Study
The HEARTBEAT Study
The Heartbeat Study is a research study from Tulane University scientists and machine learning experts in collaboration with Samsung Research America.
The study hopes to determine if data collected from wearable devices like smartwatches can be used to predict cardiovascular events. The study further aims to analyze biometric signals such as patterns of heart rate, heart rate variability, oxygen saturation and other signals collected from the smart watch to create a model for different heart diseases.
Wearable Technology
The Impact of Digital Health Devices
Currently, about 20% of the U.S. adult population utilizes digital health technologies which has revolutionized the field of cardiovascular monitoring. These devices can monitor or predict a range of cardiovascular parameters such as heart rate, blood pressure, and blood oxygen saturation.
This advancement is not only significant for its non-invasive nature but also for its potential to monitor and predict health status changes, offering a rich array of clinically relevant data.
Study Details
The HEARTBEAT Study project is an observational prospective cohort study leveraging the Samsung Galaxy Smartwatch to study the association between different biometric signal patterns and the incidence of cardiovascular events.
Other study goals include:
- Establishing biometric fingerprints for disease identification and labeling.
This study will include 10,000 patients older than 18 years who fulfill any of the following inclusion criteria:
- Patients with at least one cardiovascular disease (heart failure, cardiac arrhythmias, chronic kidney disease, coronary artery disease, history of stroke/TIA, or diabetes mellitus).
OR:
- Patients visiting a primary care provider for any reason without any of the previously mentioned cardiovascular diseases. (Healthy cohort, limited up to 500 patients throughout the study).
Eligibility
The HEARTBEAT study does not and shall not discriminate on the basis of race, color, religion (creed), gender, gender expression, age, national origin (ancestry), disability, marital status, sexual orientation, or military status, in the operations of its clinical research study.
Duration
The duration of the study will be one year for each participant. During this time, patients will be followed up for one year using a Samsung Galaxy Smartwatch and a companion smartphone application. Electronic medical records (EMR) will be surveyed for medical and clinical patient data.
Technology
All HEARTBEAT participants will use the HEARTBEAT app from their smartphone and a Samsung Galaxy Smartwatch will be delivered to each enrolled participant